# OnCo record paper-kalra-bre09-146-rucaparib-npj-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-kalra-bre09-146-rucaparib-npj-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-kalra-bre09-146-rucaparib-npj-2021" ;
  schema:name "BRE09-146: cisplatin with or without rucaparib after preoperative breast chemotherapy"@en ;
  schema:description "Adding low-dose rucaparib to cisplatin did not significantly improve the main outcome after surgery. Limited drug exposure makes this an incomplete test of other PARP strategies."@en ;
  schema:url <https://onco.cc/key-papers/paper-kalra-bre09-146-rucaparib-npj-2021/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41523-021-00240-w>, <https://pubmed.ncbi.nlm.nih.gov/33753748/> ;
  schema:sameAs <https://doi.org/10.1038/s41523-021-00240-w> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Kalra M, Tong Y, Jones DR, et al." ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/tnbc/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/rucaparib/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:trials <https://onco.cc/trials/nct01074970/> .
